alexa Cardiac Effects of Glucagon-Like Peptide 1 with Chitosan-Based Scaffold after Inducing Myocardial Infarction in Dogs

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Cardiac Effects of Glucagon-Like Peptide 1 with Chitosan-Based Scaffold after Inducing Myocardial Infarction in Dogs

Glucagon-like peptide 1 (GLP-1) is a gut-derived incretin hormone secreted in response to nutrients. GLP-1 is used in the therapeutic management of diabetes because of its gluco-regulatory effects, including augmentation of glucose-stimulated insulin secretion, suppression of postprandial glucagon secretion, delayed gastric emptying, and hypothalamus-mediated satiety of appetite. GLP-1 receptors are expressed not only in islet cells, kidney, lung, brain, and gastrointestinal tract, but also in the heart.

Citation: Zeraatian S, Salehiomran A, Aghdam RM, Tafti SHA, Ghiasi SR (2015) Cardiac Effects of Glucagon-Like Peptide 1 with Chitosan-Based Scaffold after Inducing Myocardial Infarction in Dogs. Cardiol Pharmacol 4:159.

 

 
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
 
adwords